Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adiuvo InvestmentsWAR:ADV -4.16%30 5-Year Yield-on-Cost % is 0.00 as of Jul. 27, 2026. GuruFocus rates WAR:ADV with a GF Score™ of 30/100 and a GF Value™ of zł0.47 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 323 Medical Devices & Instruments companies, Adiuvo Investments ranks worse than 309597.21% on this metric.
Adiuvo Investments's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Adiuvo Investments's 5-Year Yield-on-Cost % or its related term are showing as below:
WAR:ADV's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.51 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Adiuvo Investments 5-Year Yield-on-Cost % Related Terms
WAR:ADV vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Adiuvo Investments's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adiuvo Investments 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adiuvo Investments's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Adiuvo Investments's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Adiuvo Investments (WAR:ADV) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 27, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Adiuvo Investments and its competitors. According to the industry distribution chart, Adiuvo Investments ranks #999999 out of 323 companies in the Medical Devices & Instruments industry.
Is Adiuvo Investments' 5-Year Yield-on-Cost % too high?
Adiuvo Investments' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Adiuvo Investments ranks #999999 out of 323 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adiuvo Investments has a GF Score™ of 30/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Adiuvo Investments' 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Adiuvo Investments ranks #999999 out of 323 companies for 5-Year Yield-on-Cost %. This places Adiuvo Investments in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.51, based on 323 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Adiuvo Investments and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adiuvo Investments's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adiuvo Investments stock overvalued right now?
Based on GuruFocus' analysis, Adiuvo Investments (WAR:ADV) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.47, compared to a current price of zł0.39 — trading 16.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Adiuvo Investments' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Adiuvo Investments (WAR:ADV), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adiuvo Investments (WAR:ADV) Overvalued in 2026?
Based on GuruFocus' analysis, Adiuvo Investments stock appears to be undervalued.
The current stock price of zł0.39 is trading 16.6% below its estimated GF Value™ of zł0.47.
GuruFocus considers Adiuvo Investments to be Modestly Undervalued.
Key valuation signals for WAR:ADV:
5-Year Yield-on-Cost %: 0.00
GF Value™: zł0.47 vs. price of zł0.39 (16.6% below fair value)
No single metric tells the full story. See the WAR:ADV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adiuvo Investments SA is engaged in the selection, development, financing and commercialization of projects in the international market. The new technologies developed by the company focus on disease management, monitoring healthy lifestyle and treatment with the help of mobile devices and supplementation and functional food, or food, which in addition to nutritional properties also has health properties.
30GF Score
Get the complete analysis for WAR:ADV
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ADV has been successfully added to your 
